{
    "organizations": [],
    "uuid": "e29b97ffec5a0acccc5381b052206b1b531407d4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ionis-pharmaceuticals-qtrly-earnin/brief-ionis-pharmaceuticals-qtrly-earnings-per-share-0-02-idUSFWN1QH0NP",
    "ord_in_thread": 0,
    "title": "BRIEF-Ionis Pharmaceuticals - Qtrly Earnings Per Share $0.02",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Ionis Pharmaceuticals Inc:\n* QTRLY EARNINGS PER SHARE $0.02 * IONIS PHARMACEUTICALS - QTRLY TOTAL REVENUE $172.3 MILLION VERSUS $160.3 MILLION\n* Q4 EARNINGS PER SHARE VIEW $0.01 -- THOMSON REUTERS I/B/E/S\n* IONIS PHARMACEUTICALS - PROJECT THAT CO WILL END 2018 WITH MORE THAN $800 MILLION IN CASH Source text: ( bit.ly/2BSqONb ) Further company coverage:\n ",
    "published": "2018-02-27T19:39:00.000+02:00",
    "crawled": "2018-02-28T13:15:26.071+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "ionis",
        "pharmaceutical",
        "inc",
        "qtrly",
        "earnings",
        "per",
        "share",
        "ionis",
        "pharmaceutical",
        "qtrly",
        "total",
        "revenue",
        "million",
        "versus",
        "million",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "ionis",
        "pharmaceutical",
        "project",
        "co",
        "end",
        "million",
        "cash",
        "source",
        "text",
        "company",
        "coverage"
    ]
}